SHOCK Trial - Early Revascularization in Acute Myocardial Infarction Complicated by Cardiogenic Shock

The leading cause of death in patients hospitalized for acute myocardial infarction is cardiogenic shock. We conducted a randomized trial to evaluate early revascularization in patients with cardiogenic shock. In patients with cardiogenic shock, emergency revascularization did not significantly reduce overall mortality at 30 days. However, after six months there was a significant survival benefit. Our conclusion was that early revascularization should be strongly considered for patients with acute myocardial infarction complicated by cardiogenic shock. We are making original data that was collected for this trial available here for further analysis.